Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morange

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Cardiology Reports|September 12, 2000
Fibrinolytic function and coronary riskI Juhan-Vague, P Morange, M Christine Alessi
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 15, 2001
Fat cell function and fibrinolysisM C Alessi, P Morange, I Juhan-Vague
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Fibrinogen, obesity and insulin resistanceI Juhan-Vague, P Morange, J F Renucci, et al.
Diabetes Care|November 5, 1998
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of ObesityM A Charles, P Morange, E Eschwège, et al.
Diabetes|May 1, 1997
Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular diseaseM C Alessi, F Peiretti, P Morange, et al.
Journal De Medecine Vasculaire|April 29, 2019
[Evaluation of an "Emergency Thrombosis" care system in a university-hospital department of general emergencies]A El Yaagoubi, P Michelet, B Vaïsse, et al.
Thrombosis and Haemostasis|August 24, 1999
Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary arteryF Paganelli, M C Alessi, P Morange, et al.
Human Genetics|August 21, 2001
Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphismsD A Trégouet, H Aubert, M Henry, et al.
American Journal of Hematology|July 27, 2000
Acquired inhibitor of thrombin associated with an ulcerative colitisB Granel, J Serratrice, P Disdier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Molecular characterization of a novel mutation in the factor XIII A subunit gene associated with a severe defect and an adulthood diagnosisN Trigui, C Frère, C D'Ercole, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Cardiology Reports|September 12, 2000
Fibrinolytic function and coronary riskI Juhan-Vague, P Morange, M Christine Alessi
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 15, 2001
Fat cell function and fibrinolysisM C Alessi, P Morange, I Juhan-Vague
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Fibrinogen, obesity and insulin resistanceI Juhan-Vague, P Morange, J F Renucci, et al.
Diabetes Care|November 5, 1998
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of ObesityM A Charles, P Morange, E Eschwège, et al.
Diabetes|May 1, 1997
Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular diseaseM C Alessi, F Peiretti, P Morange, et al.
Journal De Medecine Vasculaire|April 29, 2019
[Evaluation of an "Emergency Thrombosis" care system in a university-hospital department of general emergencies]A El Yaagoubi, P Michelet, B Vaïsse, et al.
Thrombosis and Haemostasis|August 24, 1999
Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary arteryF Paganelli, M C Alessi, P Morange, et al.
Human Genetics|August 21, 2001
Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphismsD A Trégouet, H Aubert, M Henry, et al.
American Journal of Hematology|July 27, 2000
Acquired inhibitor of thrombin associated with an ulcerative colitisB Granel, J Serratrice, P Disdier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Molecular characterization of a novel mutation in the factor XIII A subunit gene associated with a severe defect and an adulthood diagnosisN Trigui, C Frère, C D'Ercole, et al.
Pageof 3